These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22454071)

  • 21. U7 snRNA, a Small RNA with a Big Impact in Gene Therapy.
    Lesman D; Rodriguez Y; Rajakumar D; Wein N
    Hum Gene Ther; 2021 Nov; 32(21-22):1317-1329. PubMed ID: 34139889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The special Sm core structure of the U7 snRNP: far-reaching significance of a small nuclear ribonucleoprotein.
    Schümperli D; Pillai RS
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2560-70. PubMed ID: 15526162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M; Mattis VB; Lorson CL
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An intronic element contributes to splicing repression in spinal muscular atrophy.
    Kashima T; Rao N; Manley JL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites.
    Uchikawa H; Fujii K; Kohno Y; Katsumata N; Nagao K; Yamada M; Miyashita T
    J Hum Genet; 2007; 52(11):891-897. PubMed ID: 17851636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense-mediated exon skipping to generate soluble receptors.
    Yilmaz-Elis AS; Verbeek JS
    Methods Mol Biol; 2012; 867():209-20. PubMed ID: 22454064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U7 snRNA: A tool for gene therapy.
    Gadgil A; Raczyńska KD
    J Gene Med; 2021 Apr; 23(4):e3321. PubMed ID: 33590603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence and expression of a mouse U7 snRNA type II pseudogene.
    Phillips SC; Turner PC
    DNA Seq; 1991; 1(6):401-4. PubMed ID: 1768864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse β
    d'Arqom A; Nualkaew T; Jearawiriyapaisarn N; Kole R; Svasti S
    Hum Gene Ther; 2021 May; 32(9-10):473-480. PubMed ID: 32977730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery.
    Eckenfelder A; Tordo J; Babbs A; Davies KE; Goyenvalle A; Danos O
    Mol Ther Nucleic Acids; 2012 Jun; 1(6):e31. PubMed ID: 23344083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic therapies for RNA mis-splicing diseases.
    Hammond SM; Wood MJ
    Trends Genet; 2011 May; 27(5):196-205. PubMed ID: 21497936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide sequence of the mouse U7 snRNA gene.
    Phillips SC; Turner PC
    Nucleic Acids Res; 1991 Mar; 19(6):1344. PubMed ID: 2030952
    [No Abstract]   [Full Text] [Related]  

  • 33. Primer extension analysis of mouse U7 small nuclear RNA gene expression.
    Kirby BJ; Turner PC
    Biochem Soc Trans; 1992 Feb; 20(1):45S. PubMed ID: 1633969
    [No Abstract]   [Full Text] [Related]  

  • 34. Antisense RNA inhibition of endogenous genes.
    Stout JT; Caskey CT
    Methods Enzymol; 1987; 151():519-30. PubMed ID: 2448580
    [No Abstract]   [Full Text] [Related]  

  • 35. Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible?
    Wiwanitkit V
    Turk J Haematol; 2009 Sep; 26(3):159-60. PubMed ID: 27265503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Splicing in the Treatment of Human Disease.
    Suñé-Pou M; Prieto-Sánchez S; Boyero-Corral S; Moreno-Castro C; El Yousfi Y; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Genes (Basel); 2017 Feb; 8(3):. PubMed ID: 28245575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations.
    Ferri L; Covello G; Caciotti A; Guerrini R; Denti MA; Morrone A
    Mol Ther Nucleic Acids; 2016 Oct; 5(10):e380. PubMed ID: 27779620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense genes to induce exon inclusion.
    Nlend RN; Schümperli D
    Methods Mol Biol; 2012; 867():325-47. PubMed ID: 22454071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
    Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
    Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.